Exploring the Therapeutic Promise and Commercial Growth of Aryl Hydrocarbon Receptor Agonists
Introduction to Aryl Hydrocarbon Receptor Agonists The Aryl Hydrocarbon Receptor Agonist has become a central focus in modern biomedical research, acting as a critical molecular target for therapies addressing immune regulation, cancer, inflammation, and metabolic disorders. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that controls gene expression in response...
0 Comments 0 Shares 458 Views 0 Reviews
Sponsored
Sponsored
Sponsored
Sponsored